Document is current
Any future updates will be listed below
-
Authors
Kanwal, Madiha
Smahel, Michal https://orcid.org/0000-0002-0366-4932
Olsen, Mark
Smahelova, Jana
Tachezy, Ruth
-
Funding
Funding for this research was provided by:
the European Regional Development Fund (CZ.02.1.01/0.0/0.0/16_019/0000785)
Ministerstvo Školství, Mládeže a Tělovýchovy (LTAUSA18003, LQ1604)
- License Information
-
More Information
Article History
Received: 1 July 2020
Accepted: 6 August 2020
First Online: 18 August 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: MO is the CEO of Crenae Therapeutics which has licensed ASPH inhibitor technologies from Midwestern University. The other authors declare that they have no competing interests.
